Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07458243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population

Study acronym: ASCENT-C
StatusNot Yet Recruiting
PhaseNot specified
Started2026-11-30
View on ClinicalTrials.gov ↗

Amendment history

2026-09-26
notable
Start date pushed: 2026-10-31 → 2026-11-30
2026-08-30
minor
3 amendments v4-v6
3 re-verifications since 2026-06-25, no change to tracked fields
2026-05-23
minor
Study Identification, Study Status, Study Description v3
Study title+61 characters
A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population
2026-04-10
minor
2 amendments v1-v2
2 re-verifications since 2026-03-09, no change to tracked fields
2026-03-04
minor
Original filing
The study is a prospective, non-randomized, single-arm, multi-center registry to confirm the safe delivery of the Carotid WALLSTENT Endoprosthesis when used with the ENROUTE® Transcarotid Neuroprotection System in the Chinese population
Trial Details
NCT Number NCT07458243
Lead Sponsor Boston Scientific Corporation
Conditions Carotid Artery Stenosis
Enrollment 60 participants
Start Date 2026-11-30
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-25